• How Smartwatches are Advancing Sleep Measurement

    Clinical Research News | Artificial intelligence (AI) is reshaping how clinical researchers study sleep, which has been tested with either simple self-reporting sleep logs or cumbersome sleep studies that take place in a lab or clinic. A new AI-driven sleep-staging framework called BIDSleep was developed at the University of Massachusetts Amherst.

    Jan 20, 2026

  • Closing the Research Gap in Africa Through Decentralized Patient Engagement and Remote Trial Models

    Clinical Research News | Africa remains one of the most important yet underleveraged regions in global drug development. The continent carries a substantial share of disease burden but contributes only a small fraction of clinical trial activity. This imbalance is not driven by scientific limitations or lack of patient interest. It reflects structural constraints that traditional site centric trial models have failed to overcome at scale.

    Jan 16, 2026

  • A Stronger, More Disciplined Future for Emerging Biopharma

    Clinical Research News | With the close of 2025 came the end of a prolonged biotech winter marked by reduced funding, massive job cuts, investor skepticism, and initial public offering slowdown. The experience, while painful, helped mature the biopharma industry with operational discipline and a new playbook for how to make the case with investors moving forward.

    Jan 13, 2026

  • New In-Ear EEG Platform Opens Door to Real-World Neurological Data Collection

    Clinical Research News | A newly FDA-cleared in-ear electroencephalogram (EEG) device could significantly alter how neurological conditions are studied, screened, and monitored outside traditional clinical settings. Paris-based Naox Technologies announced at CES 2026 in Las Vegas that its medical-grade Naox Link system has received U.S. Food and Drug Administration 510(k) clearance.

    Jan 12, 2026

  • The Scope of Things: Raising the Bar for Evidence Generation in Clinical Research

    Clinical Research News | As clinical research faces mounting pressure to generate real-world evidence faster and more efficiently, non-interventional studies may be a useful tool to achieve this. Yet, they have been historically underutilized.

    Jan 8, 2026

  • Trendspotting: Embracing AI, DEI Changes, Restrategizing Research Sites

    Clinical Research News | To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News community about what they expect and look forward to in the new year. More than ever before, artificial intelligence took center stage.

    Jan 6, 2026

  • Top Stories of 2025: AI in Clinical Research, Pharmacy Recruitment, Pragmatic Trials

    Clinical Research News | In clinical research, AI was the hottest topic this year, with the Food & Drug Administration, big pharma, and researchers exploring ways generative AI can help with drug discovery, the clinical trials process, and the regulatory landscape. But clinical trials are still a personal venture, and other stories topped the list highlighting the person-to-person interaction necessary for trial success.

    Dec 29, 2025

  • Follow the Money: AL Amyloidosis Trial, Cancer Medicine Programs, Focal Refractory Epilepsy Treatment

    Clinical Research News | Protego Biopharma will advance their lead candidate, PROT-001, into a pivotal clinical trial for AL amyloidosis; BlossomHill will expand their cancer medicine programs; EpilepsyGTx will advance its lead program EPY201 through Phase 1/2a clinical trials for focal refractory epilepsy; and more.

    Dec 23, 2025

  • New Members at NORD, Pangea, AstraZeneca Collaboration, Predicting Human Toxicity

    Clinical Research News | The National Organization for Rare Disorders (NORD) adds seven new members its national NORD Rare Disease Centers of Excellence Network; Pangaea announces a multi‑year strategic collaboration with AstraZeneca; Sanford Burnham Prebys Medical Discovery Institute plan to develop computational models to predict human toxicity; and more.

    Dec 22, 2025

  • Clinical Trials Evolve: Mixed FSP/FSO Models Add Agility and Expertise

    Clinical Research News | For every day of delay in a clinical trial, sponsors lose $500,000 in prescription drug sales and incur $40,000 in direct clinical trial costs, according to the Tufts Center for the Study of Drug Development. These numbers show why speed and control matter more than ever, as drug development continues getting more complex and expensive.

    Dec 19, 2025

  • Six 2026 Site Innovation Award Finalists Named

    Clinical Research News | The 3rd Annual Site Innovation Award has just named finalists for 2026, recognizing sites and partnerships pioneering new approaches to improving clinical trials. Finalists will present their concepts in-person at SCOPE, February 3-6, 2025, in Orlando, Fla, and winners will be named during the event.

    Dec 18, 2025

  • An Expert’s Insight on Women’s Health Research Facing Setbacks

    Clinical Research News | Progress toward equitable representation of women in clinical research—formally recognized only in 1993 when the FDA directed sponsors to include women in clinical trials—has stalled, and recent federal actions may be widening long-standing scientific blind spots. The consequences reverberate through decades of drug approvals, safety failures, and missed opportunities for understanding biological differences critical to therapeutic innovation.

    Dec 17, 2025

  • Psychedelic Therapies Enter a Crucial Phase as Clinical Research Accelerates

    Clinical Research News | As psychedelic and dissociative-based medications pick up more interest, they may enter mainstream psychiatry in the coming years. Though ketamine and psilocybin are highlighted for their potential, their mechanisms—and side effects—still require further investigation.

    Dec 16, 2025

  • 2026 Participant Engagement Award Finalists Address Pediatric Patients; Lupus; Vaccine Trials; Recruitment Issues

    Clinical Research News | Finalists have been announced in the 10th annual Participant Engagement Awards. Four projects from Biogen, Proximity Health Solutions, and BlackDoctor.org; Empath Labs; PACT; and Science 37 and RxE2 will be presented during a live judging session at SCOPE in Orlando, Florida, Feb 2-5, 2026.

    Dec 11, 2025

  • The Scope of Things: Practical Regulations Strategies for Clinical Efficiency

    Clinical Research News | The FDA’s decades-old regulation 21 CFR Part 11—which establishes criteria for electronic records and signatures to be considered trustworthy and equivalent to paper records—is in dire need of an update. Doug Bain, founder and consulting partner of ClinFlo, has his own proposal on reformations to streamline clinical trials and improve experiences for patients, sites, and sponsors, which he discusses extensively in this month’s episode of the Scope of Things.

    Dec 9, 2025

  • Statistical Considerations in Decentralized Clinical Trials

    Clinical Research News | Decentralized clinical trials (DCTs) aim to harness the power of technology to lower the burden of clinical trial participation, increase engagement and improve outreach and diversity. However, for these benefits to be realized, we need to understand the specific challenges created by DCTs and how to mitigate them.

    Dec 5, 2025

  • Next-Generation Immunotherapy Nears the Clinic with Dual Cancer Trials

    Clinical Research News | Glycans are the complex sugar chains found at abnormally high levels on the surface of cancer cells—and one of the toughest challenges in cancer treatment. A research team from the UC Irvine School of Medicine developed glycan-dependent T cell recruiters (GlyTRs), which represent a first-of-its-kind approach that bypasses traditional antibody mechanisms to attack cancer’s sugar-coated armor.

    Dec 3, 2025

  • Space Health Research Could Rack Up Many Earthly Dividends

    Clinical Research News | When the first all-civilian spaceflight, Inspiration4, was launched by SpaceX in 2021, it set into orbit the idea of future space habitation. It also marked the start of a long-term mission to understand the impact of the journey on everyday people without extensive astronaut training.

    Dec 2, 2025

  • Follow the Money: Hypertrophic Cardiomyopathy Therapeutic Candidate, Underserved Bleeding Disorders, Rare Disease Trials

    Clinical Research News | Braveheart will advance their small molecule therapeutic candidate, BHB-1893, for hypertrophic cardiomyopathy; Hemab Therapeutics will keep developing sutacimig as the first-ever prophylactic treatment for Glanzmann thrombasthenia (GT); AAVantgarde will continue to work on their trials for treatments for Stargardt disease and Usher 1B; and more.

    Nov 25, 2025

  • Walgreens Launches New Patient Advisory Board, Advocate Health National Center for Clinical Trials Announced, P95, Julius Clinical Merge

    Clinical Research News | Walgreens launches the Walgreens Pharmacy Patient Advisory Board; Advocate Health announces Advocate Health National Center for Clinical Trials, the U.S.’s first, largest, and most inclusive clinical trial network; P95 and Julius Clinical have merged to form a global, full-service clinical research organization; and more.

    Nov 24, 2025